YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
AngioDynamics, Inc. ANGO reported an adjusted loss per share of 4 cents for first-quarter fiscal 2027, narrower than the year-ago quarter's adjusted loss of 10 cents. The figure also beat the consensus estimate by 60%. Revenues totaled $80…
Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid second-quarter fiscal 2027 performance and CRM migrations, is expected to contribute further.…
Veracyte has seen its stock build a long upward track record, and the question now is whether the current share price lines up with the cash flows the business is expected to generate. With investors watching new clinical data around its D…
Phibro Animal Health's PAHC Animal Health segment is gaining momentum from strong legacy demand, Zoetis medicated feed additives (MFA) acquisition and broad product growth. The vaccine business is expanding on higher demand, capacity inves…
Smith+Nephew SNN recently announced the European commercial launch of its CARTIHEAL AGILI-C Cartilage Repair Implant, expanding the availability of its cartilage repair technology across key markets in the region. The launch marks another…
Bruker Corporation BRKR has witnessed strong momentum over the past year. Shares of the company have risen 66.3% compared with the industry's 66.4% growth. The S&P 500 composite has increased 18.2% during the same time frame. With healthy…
HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid second-quarter fiscal 2027 performance and strength in Health Savings Accounts (HSAs), is expected to contribute further. However, d…
Veeva Systems VEEV continues to strengthen its position in the life sciences software market as its Veeva DQS (Data Quality System) platform expands its reach across clinical trials. The company said that the solution has now supported dat…
Globus Medical, Inc. GMED is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical instruments. Also, product innovation and so…
Charles River Laboratories International CRL has witnessed strong momentum over the past year. Shares of the company have risen 75.8%, outperforming the industry's 10.5% growth. The S&P 500 composite has increased 16.1% during the same tim…
Thermo Fisher Scientific Inc. TMO is strengthening growth through innovation, artificial intelligence (AI) investments, customer partnerships and a broad commercial engine. Targeted acquisitions are further broadening its capabilities acro…
Teleflex's TFX Vascular business is well-positioned for growth in the upcoming quarters, led by sustained demand for central access and hemostatic products, coupled with new product introductions such as EZPLAZ. Further, the company's expa…
Veeva Systems VEEV recently announced that Servier has selected Veeva OpenData to standardize customer reference data across more than 80 countries. The move strengthens Veeva's position as a key provider of data solutions for global life…
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Cathie Wood-led Ark Invest trimmed its position in Palantir Technologies Inc. on Thursday, as the artificial intelligence software company…
Veracyte (VCYT) is back in focus after new phase III data on its Decipher Prostate Genomic Classifier showed it can help identify which intermediate-risk prostate cancer patients benefit most from adding short-term hormone therapy. Investo…
Veracyte, Inc. recently presented retrospective ancillary Phase III NRG/RTOG 0815 trial data at the 2026 ASTRO meeting, showing that its Decipher Prostate Genomic Classifier can stratify which intermediate-risk prostate cancer patients ben…
Veracyte (NasdaqGM:VCYT) reported new phase III data showing its Decipher Prostate Genomic Classifier can guide hormone therapy use with radiation in intermediate-risk prostate cancer. The phase III trial provided prospective evidence that…
Neogen NEOG shares have shown impressive momentum so far this year, surging 83%. The stock has outpaced the industry's 21.6% fall and the S&P 500 composite's 11.7% rise. Carrying a Zacks Rank #2 (Buy) at present, the company's Food Safety…
Smith+Nephew SNN recently launched the new EVOS PELVIC Plating System, expanding its EVOS trauma platform into pelvic and acetabular fracture management. The launch strengthens the company's orthopedic trauma portfolio by adding a dedicate…
10x Genomics, Inc. TXG recently began commercial shipments of Atera, its next-generation spatial biology platform designed to combine whole-transcriptome analysis, sub-cellular resolution and single-cell sensitivity at scale. The launch ma…
Integra LifeSciences Holdings Corporation IART sees steady demand across Specialty Surgery, supported by neurosurgery strength, better supply reliability and emerging ear, nose and throat (ENT) opportunities. The company is improving opera…
McKesson's MCK prospects are being driven by robust growth in specialty distribution, oncology services and biopharma solutions. Earnings are also improving on the back of ongoing operational efficiency and capital discipline despite persi…
Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated insulin delivery (AID) platform and Senseonics' continuous glucose monitoring technology. The collaboration is expe…
Integer Holdings Corporation ITGR has been gaining from its research and product development activities. The optimism, led by a mixed second-quarter 2026 performance and its strength in core product franchises, is expected to contribute fu…
Revvity, Inc. RVTY is well-positioned for growth, thanks to its strong product portfolio. The company is positioned for growth across diagnostics, life sciences and scientific informatics. Diagnostics remains a key growth engine, while new…
Fresenius Medical Care AG & Co. FMS recently refined its China commercial strategy to focus on areas offering stronger long-term growth potential and strengthen its position in the country's dialysis market. The company plans to prioritize…
Veracyte, Inc. First predictive evidence in intermediate-risk prostate cancer supporting use of the Decipher test to guide short-term hormone therapy decisions to be presented at ASTRO 2026 SOUTH SAN FRANCISCO, Calif., Sept. 29, 2026 (GLOB…
Labcorp Holdings Inc. LH, or Labcorp, is expanding in high-growth specialty testing markets while broadening its consumer testing business. Acquisitions, health-system relationships and new contracts are boosting the company's reach and su…
This article first appeared on GuruFocus. Cathie Wood's Ark Invest made a fresh round of high-conviction bets last week, adding heavily to Meta Platforms (NASDAQ:META) and Rocket Lab (NASDAQ:RKLB) while cutting exposure to several technolo…
GE HealthCare Technologies, Inc. GEHC is well positioned for growth in the coming quarters, supported by record backlog and order momentum, continued strength in its Pharmaceutical Diagnostics business and an expanding pipeline of AI-enabl…
Becton, Dickinson and Company BDX is benefiting from its focused transformation into a pure-play MedTech company, supported by strong execution of its BD 2025 strategy. The company's continued emphasis on innovation, strategic partnerships…
OPKO Health, Inc. OPK is well-positioned for growth in the coming quarters, supported by the potential of RAYALDEE. Optimism surrounding the stock is driven by RAYALDEE's strong performance, strategic partnerships, BioReference restructuri…
Biodesix BDSX recently announced strategic progress in two molecular residual disease (MRD) programs to expand access to blood-based cancer monitoring. The company is developing tumor-informed and tumor-naive solutions that detect circulat…
Cathie Wood’s Ark Invest boosted its technology, biotechnology, and space exposure last week, led by purchases of more than 51K shares of Meta Platforms (META [https://seekingalpha.com/symbol/META]) worth $38.2M and roughly 360K shares of…
Veracyte, Inc. Six oral presentations and two posters will highlight Decipher's prognostic and predictive value in identifying patients' risk of progression and likelihood of benefiting from treatment intensification SOUTH SAN FRANCISCO, C…
Veeva Systems VEEV recently introduced Veeva Study Builder Agent, a new AI-powered solution designed to accelerate clinical study configuration within its Clinical Data platform. The launch reinforces Veeva's push to embed AI across its li…